跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈在新的选项卡/窗口中打开

Elsevier
通过我们出版

Future of Autoimmunity Research

Aim & scope

Future of autoimmunity research is a major new suite of books in autoimmunity, which cover both basic and clinical research. The series seeks to discuss and provide foundational content from bench to bedside in autoimmune diseases

The Series’ goal is to enhance knowledge, and present update on hot topics in the field of autoimmunity; specifically, the series aims to translate results and recent findings of studies into clinical practice.

Written and edited by leading international scientists, the series is primarily intended for researchers, clinicians, and students in autoimmune diseases at the graduate level and above, including those working in academic, corporate, or non-profit settings. Its ethics mission is to enable global benefit sharing of advances in the field of autoimmunity through the publication of foundational, consensus building content.

The Future of autoimmunity research series seeks to provide wide coverage across areas of autoimmunity. Possible subject areas covered by Series Volumes include: Autoimmune diseases; COVID and Autoimmunity, Post COVID syndrome; Autoimmune pancreatitis Controversies in Autoimmunity.

Sample cover of Future of Autoimmunity Research

Audience

Researchers, clinicians, and students in the field of immunology at the graduate level and above, including those working in academic, corporate, or non-profit settings.

Secondary Markets

Immunologists, clinical immunologists and allergists, rheumatologists, haematologists and oncologists, and paediatricians

Series Editor

Image of Yehuda Shoenfeld

YS

Yehuda Shoenfeld

Founder & Head

Tel-Aviv University, Department of Medicine, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer 5265601, Israel

阅读更多有关 Yehuda Shoenfeld 的信息